Brain Cancer Clinical Trials in Nashville

Showing 61-80 of 159 trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02386826

The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.

Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more

SCRI Development Innovations, LLC65 participantsStarted Sep 2015

Denver, Colorado, United States • New Haven, Connecticut, United States • Kansas City, Missouri, United States +2 more locations

COMPLETEDPhase 3155 miles

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

NCT03149003

This is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

Glioblastoma

Sumitomo Pharma America, Inc.221 participantsStarted Dec 2017

Birmingham, Alabama, United States • Tucson, Arizona, United States • Fayetteville, Arkansas, United States +58 more locations

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Brain Cancer Trials in Other Cities

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Laser Ablation After Stereotactic Radiosurgery

Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Other Conditions in Nashville